Brand Name: Imfinzi Injection
Prescription Required
Marketer: AstraZeneca
Salt Composition: Durvalumab (120mg)
Treatment: Imfinzi Injection is used in the treatment of Urinary bladder cancer, Non-small cell lung cancer.
Storage: Store below 30°C

The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer:

• Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
• Adults with unresectable, Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
• In combination with etoposide and either carboplatin or cisplatin, as first-line treatment for adults with extensive-stage small cell lung cancer.
• In combination with gemcitabine and cisplatin for adults with locally advanced or metastatic biliary tract cancer (BTC).